कृपया अन्य खोज का प्रयास करें
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
David L. Hallal | 55 | 2017 | Independent Chairman of the Board |
Lynn Sakai | - | - | Member of Scientific Advisory Board |
Kristina M. Burow | 49 | 2014 | Independent Director |
Akshay K. Vaishnaw | 59 | 2014 | Independent Director & Member of Scientific Advisory Board |
Jeffrey S. Flier | 74 | 2016 | Independent Director & Member of Scientific Advisory Board |
Joshua Reed | 49 | 2021 | Independent Director |
Timothy A. Springer | 74 | 2012 | Member of Scientific Advisory Board |
Michael Gilman | 67 | 2013 | Independent Director & Member of Scientific Advisory Board |
Leonard I. Zon | - | - | Member of Scientific Advisory Board |
Scott L. Friedman | - | - | Member of Scientific Advisory Board |
Barry S. Coller | - | - | Member of Scientific Advisory Board |
Joan Massague | 69 | - | Member of Scientific Advisory Board |
Daniel B. Rifkin | - | - | Member of Scientific Advisory Board |
Amir H. Nashat | 49 | 2012 | Independent Director |
Shelia M. Violette | - | - | Member of Scientific Advisory Board |
Srinivas Akkaraju | 54 | 2022 | Independent Director |
Richard Brudnick | 66 | 2023 | Independent Director |
Jay T. Backstrom | 68 | 2022 | President, CEO & Director |
Katie Peng | 53 | 2024 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है